The Swedish market will close at 13:00 on 2 April. The Norwegian and Danish markets will be closed on 2 April. On 3 and 6 April, the Swedish, Norwegian and Danish markets will be closed.

SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

+/-
%
()

Board

CEO

  • Gabriela Godaly (tf)

Chairperson of the Board

  • Catharina Svanborg

Board

  • Carl-Johan Wachtmeister
  • Gabriela Godaly
  • Helena Lomberg